IFI (n = 99, 100%) | ENI (n = 70, 100%) | |
---|---|---|
Failure | 53 (53%) | 41 (59%) |
In field recurrence | 32 (32%) | 21 (30%) |
Alone | 27 (27%) | 17 (24%) |
+ out-PTVeni cervical nodes | 1 (1%) | 1 (1%) |
+ out-PTVifi in-PTVeni nodes | 4 (4%) | 3 (4%) |
Isolated out-PTVifi in-PTVeni nodes | 3 (3%) | 2 (3%) |
Isolated out-PTVeni cervical nodes | 0 | 0 |
Out-PTVeni mediastinal nodes | 2 (2%) | 2 (3%) |
Alone | 0 | 0 |
+ out-PTVifi in PTVeni nodes | 0 | 1 (1%) |
+ with other distal nodes | 2 (2%) | 1 (1%) |
Distal organ metastasis | 15 (15%) | 14 (20%) |
Alone | 8 (8%) | 7 (10%) |
+ in field recurrence | 6 (6%) | 5 (7%) |
+ out-PTVifi in-PTVeni nodes | 1 (1%) | 2 (3%) |
Secondary esophageal tumor | 1 (1%) | 2 (3%) |
Alone | 1 (1%) | 1 (1%) |
+ out-PTVifi in-PTVeni nodes | 0 | 1 (1%) |